FDA is trying to make it easier for companies to bring COVID-19 testing to the market as a screening tool for asymptomatic people not suspected of having the virus and for sample pooling. The agency also slapped three companies with warning letters for selling fraudulent COVID-19 antibody test kits online, and revoked Chembio’s antibody test authorization.
